The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in

Featured videos videos

Masterclass: Treating dyslipidaemia – special populations

In this masterclass, Alison Pottle and Jai Cegla provide discuss screening for familial hypercholesterolaemia (FH), treatment advances in dyslipidaemia, the role of lipid apheresis in specific populations and the importance of patient education.

Key highlights from Heart Failure 2024 – Annual congress of the Heart Failure Association of the ESC

Professor Paul Kalra summarises key findings presented at the 2024 Heart Failure Association ESC meeting in Lisbon. He discusses the new data on hypertrophic cardiomyopathy, heart failure with reduced ejection fraction, and challenges in diagnosis and treatment optimisation. He also explores the early benefits of sodium-glucose co-transporter 2 inhibitors and evidence-based treatments for heart failure with preserved ejection fraction.

Sport and the heart

Many of us understand the importance of exercise to improve not only our cardiovascular health, but health in general. Despite healthier living, cardiac-related injury or even death can occur in those who appear physically healthy, even athletes. Join Dr Gherardo Finocchiaro as he discusses the aetiology and epidemiology of sudden cardiac death, and the importance of cardiac screening, diagnosis and risk minimisation.

Masterclass: Looking at lipids – dyslipidemia in CVD prevention

Watch Terry McCormack and Peter Green discuss the national guidelines for primary and secondary prevention of cardiovascular disease (CVD), risk assessment and recommended lipid targets for CVD, and the availability of smart open-access data tools that can reduce health inequalities and improve treatment outcomes for your patients.

The COVID-19 cardiovascular legacy: long COVID and its complications

COVID-19, and specifically long COVID, is associated with an increased risk of cardiovascular disease. Listen as Professor Banerjee describes his work in this area, especially the STIMULATE-ICP trial, which looks at long COVID’s physiological and social impact. Find out about what the NHS is doing to tackle COVID-19 and its associated cardiovascular and metabolic abnormalities.

Virtual wards, virtual hospitals – virtual success and here to stay?

Medical technology is rapidly evolving, leading to numerous innovations in healthcare. One such development is the introduction of virtual wards. Join Niall Keenan (West Hertfordshire Teaching Hospitals NHS Trust) as he provides an insight into the benefit of virtual wards. Niall also discusses promising advancements in technology, how virtual wards were implemented locally and what developments we can expect in the future.
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.